GSK

V0128325

GSK

:
Orð- og myndmerki
:
1695161
:
Skráð

08.06.2022
15.2.2024
15.04.2024
15.4.2024
8.6.2032
  • :
    08.06.2022
  • :
    15.2.2024
  • :
    15.4.2024
  • :
    15.4.2024
  • :
    27.05
  • :
    SmithKline Beecham Limited
  • :
    79 New Oxford Street, London WC1A 1DG, GB
  • :
    2022001165
  • :
    9.2.2022
  • :
    Kosta Ríka
  • 5

    Pharmaceutical and medicinal preparations and substances; chemical, biochemical and biological preparations and agents for medical purposes; therapeutic agents (medical); adhesive patches for medical purposes; adhesive patches for surgical purposes; adhesive patches incorporating a pharmaceutical preparation; medicated patches, plasters and dressings for the treatment of skin diseases, conditions and disorders; vaccines; adjuvants for medical purposes; vitamins, minerals and food supplements; dietary preparations; dietary supplements and dietetic preparations; diagnostic preparations; disinfectants and antiseptics; medical dressings and medical plasters; pharmaceuticals and natural remedies; medicated and sanitising soaps and detergents; sanitary preparations and articles; drug delivery agents that facilitate the delivery of pharmaceutical preparations.

  • 10

    Surgical and medical apparatus and instruments; inhalers; injectors for medical purposes; medical apparatus and instruments for use in the diagnosis and treatment of skin diseases, conditions and disorders; artificial skin for surgical purposes; artificial skin replacing membranes; suture materials; skin biopsy punches; surgical punches; apparatus for carrying out diagnostic tests of the skin for medical purposes; medical and diagnostic apparatus for allergy testing; transcutaneous electrical nerve stimulation devices to treat body pain; bioelectronic treatment devices for medical purposes; implantable electrodes for medical purposes; adaptive open and or closed-loop bioelectronic medical devices that deliver stimulation and/or blocking to a nerve and optionally can record incoming action potentials and physiological parameters, analyse data in real time and modulate neural signalling; drug delivery devices for the deferred, controlled or immediate release of pharmaceutical preparations into the human body; sleep monitoring devices for medical purposes; electromagnetic therapy devices and electromagnetic apparatus for medical purposes; infrared therapy devices and infrared apparatus for medical purposes; ultrasound therapy devices and ultrasound apparatus for medical purposes; laser therapy devices and laser apparatus for medical purposes; diagnostic apparatus for medical purposes; electronic instruments for medical use; thermometers for medical use; cooling patches for medical use; parts and fittings for all aforesaid goods; artificial organs and implants; contraceptive devices; diagnostic, examination, and monitoring equipment; suture and wound closing materials and products; surgical and wound treating equipment; prosthetics and artificial implants; medical imaging apparatus; diagnostic apparatus for medical purposes; electronic monitoring instruments for medical use; medical instruments for recording, collecting and storing physiological data; applicators for pharmaceutical preparations; receptacles for applying medicines.

  • 42

    Scientific research for medical and healthcare purposes; research and development services in the fields of bioelectronics, drug discovery, drug discovery products, pharmaceuticals, medicinal diagnostics, biochemicals, biotechnology, biological products, medical apparatus, devices and instruments; conducting clinical trials; genetic testing and genetic fingerprinting for research purposes; scientific consulting; supply of information in the area of laboratory technology; medical laboratory services; provision of scientific information; design of computational models and systems of artificial intelligence; medical and pharmacological research services; scientific and technological services; testing, authentication and quality control; software development, programming and implementation; scientific research in the field of gene and cell therapy; provision of information, consultancy and advisory services relating to any of the aforesaid services.